VitaDAO: Pfizer-Invested Longevity Research, A New Paradigm for Decentralized Science?
wublock.substack.com
Author: @0xMavWisdom On 30 January, DeSci track longevity startup VitaDAO announced the completion of a $4.1 million funding round from Balaji Srinivasan, former CTO of Coinbase, and Pfizer Ventures, the investment arm of Pfizer, the world's largest pharmaceutical company, marking Pfizer's first investment in the Web3 space. VitaDAO will use the funding to further fund longevity research projects and biotech startups that will be spun out of DAO next year. As a result of the news, the VitaDAO governance Token VITA rose by 60% in a short period of time.
VitaDAO: Pfizer-Invested Longevity Research, A New Paradigm for Decentralized Science?
VitaDAO: Pfizer-Invested Longevity Research…
VitaDAO: Pfizer-Invested Longevity Research, A New Paradigm for Decentralized Science?
Author: @0xMavWisdom On 30 January, DeSci track longevity startup VitaDAO announced the completion of a $4.1 million funding round from Balaji Srinivasan, former CTO of Coinbase, and Pfizer Ventures, the investment arm of Pfizer, the world's largest pharmaceutical company, marking Pfizer's first investment in the Web3 space. VitaDAO will use the funding to further fund longevity research projects and biotech startups that will be spun out of DAO next year. As a result of the news, the VitaDAO governance Token VITA rose by 60% in a short period of time.